Theravance Biopharma, Inc. Reports Second Quarter 2017 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Theravance Biopharma, Inc. Reports Second Quarter 2017 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Misses Q2 EPS by 13c

August 8, 2017 4:48 PM EDT

Theravance Biopharma (NASDAQ: TBPH) reported Q2 EPS of ($1.27), $0.13 worse than the analyst estimate of ($1.14). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $4.66 million.

Cash, cash equivalents and marketable securities, excluding restricted cash, totaled $498.3 million as of June 30,... More